First Manhattan’s Core Laboratories CLB Stock Holding History

First Manhattan’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,250	Closed	-$21.3K	–	777
2024 Q1	$21.3K	Hold	1,250	–	–	﹤0.01%	1020
2023 Q4	$22.1K	Hold	1,250	–	–	﹤0.01%	1014
2023 Q3	$30K	Hold	1,250	–	–	﹤0.01%	965
2023 Q2	$29.1K	Buy	1,250 +1,212	+3,189%	+$27.4K	﹤0.01%	972
2023 Q1	$837	Hold	38	–	–	﹤0.01%	1443
2022 Q4	$770	Hold	38	–	–	﹤0.01%	1595
2022 Q3	$0	Hold	38	–	–	﹤0.01%	1530
2022 Q2	$0	Hold	38	–	–	﹤0.01%	1556
2022 Q1	$1K	Hold	38	–	–	﹤0.01%	1523
2021 Q4	$0	Hold	38	–	–	﹤0.01%	1578
2021 Q3	$1K	Hold	38	–	–	﹤0.01%	1542
2021 Q2	$1K	Hold	38	–	–	﹤0.01%	1523
2021 Q1	$1K	Hold	38	–	–	﹤0.01%	1435
2020 Q4	$1K	Hold	38	–	–	﹤0.01%	1296
2020 Q3	$0	Sell	38 -141	-79%	-$2.96K	﹤0.01%	1339
2020 Q2	$3K	Hold	179	–	–	﹤0.01%	1289
2020 Q1	$1K	Buy	179 +31	+21%	+$867	﹤0.01%	1327
2019 Q4	$5K	Sell	148 -175	-54%	-$7.86K	﹤0.01%	1197
2019 Q3	$15K	Hold	323	–	–	﹤0.01%	1100
2019 Q2	$16K	Hold	323	–	–	﹤0.01%	1115
2019 Q1	$22K	Buy	323 +148	+85%	+$9.92K	﹤0.01%	1076
2018 Q4	$10K	Sell	175 -100	-36%	-$8.63K	﹤0.01%	1160
2018 Q3	$31K	Hold	275	–	–	﹤0.01%	1057
2018 Q2	$34K	Buy	275 +100	+57%	+$12.2K	﹤0.01%	1017
2018 Q1	$18K	Hold	175	–	–	﹤0.01%	1113
2017 Q4	$19K	Hold	175	–	–	﹤0.01%	1161
2017 Q3	$17K	Hold	175	–	–	﹤0.01%	1145
2017 Q2	$17K	Hold	175	–	–	﹤0.01%	1106
2017 Q1	$20K	Hold	175	–	–	﹤0.01%	1092
2016 Q4	$21K	Sell	175 -110	-39%	-$12.2K	﹤0.01%	1061
2016 Q3	$32K	Hold	285	–	–	﹤0.01%	1001
2016 Q2	$35K	Buy	285 +110	+63%	+$13.3K	﹤0.01%	1020
2016 Q1	$19K	Hold	175	–	–	﹤0.01%	1068
2015 Q4	$19K	Hold	175	–	–	﹤0.01%	1092
2015 Q3	$17K	Hold	175	–	–	﹤0.01%	1110
2015 Q2	$19K	Hold	175	–	–	﹤0.01%	1114
2015 Q1	$18K	Sell	175 -100	-36%	-$10.7K	﹤0.01%	1132
2014 Q4	$33K	Buy	275 +175	+175%	+$23K	﹤0.01%	1051
2014 Q3	$14K	Buy	+100	New	+$15.4K	﹤0.01%	1154

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

First Manhattan's CLB Position: Q2 2024 in Review

First Manhattan sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 1,250 shares — an estimated $21.3K sold.

First Manhattan first reported a position in CLB in Q3 2014 and held it in 39 quarters. The position peaked at $35K in Q2 2016. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

First Manhattan reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 1,250 Core Laboratories shares in Q2 2024, an estimated $21.3K.
First Manhattan first reported a position in Core Laboratories in Q3 2014 and held it in 39 quarters.
First Manhattan's Core Laboratories position peaked at $35K in Q2 2016.
194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.